-
Je něco špatně v tomto záznamu ?
Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE study
J. Neuzner, SH. Hohnloser, V. Kutyifa, M. Glikson, T. Dietze, P. Mabo, X. Vinolas, J. Kautzner, G. O'Hara, T. Lawo, J. Brachmann, L. VanErven, F. Gadler, U. Appl, J. Wang, SJ. Connolly, JS. Healey,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu srovnávací studie, časopisecké články, pozorovací studie
NLK
CINAHL Plus with Full Text (EBSCOhost)
od 1990-02-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1990-02-01 do Před 1 rokem
PubMed
30945798
DOI
10.1111/jce.13943
Knihovny.cz E-zdroje
- MeSH
- časové faktory MeSH
- defibrilátory implantabilní * MeSH
- elektrická defibrilace škodlivé účinky přístrojové vybavení mortalita MeSH
- lidé středního věku MeSH
- lidé MeSH
- náhlá srdeční smrt prevence a kontrola MeSH
- příčina smrti MeSH
- primární prevence přístrojové vybavení MeSH
- protézy - design MeSH
- randomizované kontrolované studie jako téma MeSH
- rizikové faktory MeSH
- sekundární prevence přístrojové vybavení MeSH
- selhání protézy MeSH
- senioři MeSH
- srdeční arytmie diagnóza mortalita patofyziologie terapie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
- srovnávací studie MeSH
INTRODUCTION: Dual-coil leads (DC-leads) were the standard of choice since the first nonthoracotomy implantable cardioverter/defibrillator (ICD). We used contemporary data to determine if DC-leads offer any advantage over single-coil leads (SC-leads), in terms of defibrillation efficacy, safety, clinical outcome, and complication rates. METHODS AND RESULTS: In the Shockless IMPLant Evaluation study, 2500 patients received a first implanted ICD and were randomized to implantation with or without defibrillation testing. Two thousand and four hundred seventy-five patients received SC-coil or DC-coil leads (SC-leads in 1025/2475 patients; 41.4%). In patients who underwent defibrillation testing (n = 1204), patients with both lead types were equally likely to achieve an adequate defibrillation safety margin (88.8% vs 91.2%; P = 0.16). There was no overall effect of lead type on the primary study endpoint of "failed appropriate shock or arrhythmic death" (adjusted HR 1.18; 95% CI, 0.86-1.62; P = 0.300), and on all-cause mortality (SC-leads: 5.34%/year; DC-leads: 5.48%/year; adjusted HR 1.16; 95% CI, 0.94-1.43; P = 0.168). However, among patients without prior heart failure (HF), and SC-leads had a significantly higher risk of failed appropriate shock or arrhythmic death (adjusted HR 7.02; 95% CI, 2.41-20.5). There were no differences in complication rates. CONCLUSION: In this nonrandomized evaluation, there was no overall difference in defibrillation efficacy, safety, outcome, and complication rates between SC-leads and DC-leads. However, DC-leads were associated with a reduction in the composite of failed appropriate shock or arrhythmic death in the subgroup of non-HF patients. Considering riskier future lead extraction with DC-leads, SC-leads appears to be preferable in the majority of patients.
Ambulantes Herzzentrum Kassel Kassel Germany
Boston Scientific Minneapolis Minnesota Boston Scientific Brussels Belgium
Centre Hospitalier Universitaire Rennes France
Department of Cardiology University Hospital Frankfurt Goethe University Frankfurt Germany
Elisabeth Krankenhaus Recklinghausen Germany
Hospital de Santa Creu 1 Saint Pau Barcelona Spain
Institute for Clinical and Experimental Medicine Prague Czech Republic
Institute Universitaire de Cardiologie et de Pneumologie de Quebec QC Canada
Karolinska Hospital Stockholm Sweden
Klinikum Kassel Kassel Germany
Leiden University Medical Center Leiden the Netherlands
Leviev Heart Center Sheba Medical Center Tel Hashomer Israel
Mc Master University Hamilton Canada
Population Health Research Institute Hamilton Canada
Population Health Research Institute Hamilton Canada Mc Master University Hamilton Canada
Regiomed Kliniken Coburg Germany
Semmelweis University Budapest Hungary University of Rochester Medical Center Rochester New York
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025803
- 003
- CZ-PrNML
- 005
- 20201222155432.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jce.13943 $2 doi
- 035 __
- $a (PubMed)30945798
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Neuzner, Jörg $u Klinikum Kassel, Kassel, Germany.
- 245 10
- $a Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE study / $c J. Neuzner, SH. Hohnloser, V. Kutyifa, M. Glikson, T. Dietze, P. Mabo, X. Vinolas, J. Kautzner, G. O'Hara, T. Lawo, J. Brachmann, L. VanErven, F. Gadler, U. Appl, J. Wang, SJ. Connolly, JS. Healey,
- 520 9_
- $a INTRODUCTION: Dual-coil leads (DC-leads) were the standard of choice since the first nonthoracotomy implantable cardioverter/defibrillator (ICD). We used contemporary data to determine if DC-leads offer any advantage over single-coil leads (SC-leads), in terms of defibrillation efficacy, safety, clinical outcome, and complication rates. METHODS AND RESULTS: In the Shockless IMPLant Evaluation study, 2500 patients received a first implanted ICD and were randomized to implantation with or without defibrillation testing. Two thousand and four hundred seventy-five patients received SC-coil or DC-coil leads (SC-leads in 1025/2475 patients; 41.4%). In patients who underwent defibrillation testing (n = 1204), patients with both lead types were equally likely to achieve an adequate defibrillation safety margin (88.8% vs 91.2%; P = 0.16). There was no overall effect of lead type on the primary study endpoint of "failed appropriate shock or arrhythmic death" (adjusted HR 1.18; 95% CI, 0.86-1.62; P = 0.300), and on all-cause mortality (SC-leads: 5.34%/year; DC-leads: 5.48%/year; adjusted HR 1.16; 95% CI, 0.94-1.43; P = 0.168). However, among patients without prior heart failure (HF), and SC-leads had a significantly higher risk of failed appropriate shock or arrhythmic death (adjusted HR 7.02; 95% CI, 2.41-20.5). There were no differences in complication rates. CONCLUSION: In this nonrandomized evaluation, there was no overall difference in defibrillation efficacy, safety, outcome, and complication rates between SC-leads and DC-leads. However, DC-leads were associated with a reduction in the composite of failed appropriate shock or arrhythmic death in the subgroup of non-HF patients. Considering riskier future lead extraction with DC-leads, SC-leads appears to be preferable in the majority of patients.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a srdeční arytmie $x diagnóza $x mortalita $x patofyziologie $x terapie $7 D001145
- 650 _2
- $a příčina smrti $7 D002423
- 650 _2
- $a náhlá srdeční smrt $x prevence a kontrola $7 D016757
- 650 12
- $a defibrilátory implantabilní $7 D017147
- 650 _2
- $a elektrická defibrilace $x škodlivé účinky $x přístrojové vybavení $x mortalita $7 D004554
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a primární prevence $x přístrojové vybavení $7 D011322
- 650 _2
- $a protézy - design $7 D011474
- 650 _2
- $a selhání protézy $7 D011475
- 650 _2
- $a randomizované kontrolované studie jako téma $7 D016032
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a sekundární prevence $x přístrojové vybavení $7 D055502
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Hohnloser, Stefan H $u Department of Cardiology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
- 700 1_
- $a Kutyifa, Valentina $u Semmelweis University, Budapest, Hungary. University of Rochester Medical Center, Rochester, New York.
- 700 1_
- $a Glikson, Michael $u Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel.
- 700 1_
- $a Dietze, Thomas $u Ambulantes Herzzentrum Kassel, Kassel, Germany.
- 700 1_
- $a Mabo, Philippe $u Centre Hospitalier Universitaire, Rennes, France.
- 700 1_
- $a Vinolas, Xavier $u Hospital de Santa Creu I Saint Pau, Barcelona, Spain.
- 700 1_
- $a Kautzner, Josef $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a O'Hara, Gilles $u Institute Universitaire de Cardiologie et de Pneumologie de, Quebec, QC, Canada.
- 700 1_
- $a Lawo, Thomas $u Elisabeth Krankenhaus, Recklinghausen, Germany.
- 700 1_
- $a Brachmann, Johannes $u Regiomed Kliniken, Coburg, Germany.
- 700 1_
- $a VanErven, Liselot $u Leiden University Medical Center, Leiden, the Netherlands.
- 700 1_
- $a Gadler, Fredrik $u Karolinska Hospital, Stockholm, Sweden.
- 700 1_
- $a Appl, Ursula $u Boston Scientific, Minneapolis, Minnesota. Boston Scientific, Brussels, Belgium.
- 700 1_
- $a Wang, Jia $u Population Health Research Institute, Hamilton, Canada.
- 700 1_
- $a Connolly, Stuart J $u Mc Master University, Hamilton, Canada.
- 700 1_
- $a Healey, Jeff S $u Population Health Research Institute, Hamilton, Canada. Mc Master University, Hamilton, Canada.
- 773 0_
- $w MED00002569 $t Journal of cardiovascular electrophysiology $x 1540-8167 $g Roč. 30, č. 7 (2019), s. 1078-1085
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30945798 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155427 $b ABA008
- 999 __
- $a ok $b bmc $g 1599948 $s 1116489
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 30 $c 7 $d 1078-1085 $e 20190422 $i 1540-8167 $m Journal of cardiovascular electrophysiology $n J Cardiovasc Electrophysiol $x MED00002569
- LZP __
- $a Pubmed-20201125